Abstract
The in vivo access of the nonpeptide angiotensin II (Ang II) antagonist, DuP 753 (10 mg kg-1, i.v.), to Ang II receptors of rat brain was investigated by in vitro autoradiography with [125I]-[Sar1, Ile8] Ang II as a ligand. DuP 753 markedly inhibited the binding to sites which contain exclusively AT1 receptors both outside and within the blood brain barrier, such as the circumventricular organs, paraventricular hypothalamic nucleus, median preoptic nucleus and nucleus of the solitary tract. However, binding to other nuclei containing AT2 receptors was not significantly inhibited. These results demonstrate that DuP 753 and/or its active metabolite readily cross the blood brain barrier in vivo and selectively inhibit binding to AT1 receptors in specific brain nuclei.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnes N. M., Champaneria S., Costall B., Kelly M. E., Murphy D. A., Naylor R. J. Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradigm. Neuroreport. 1990 Nov-Dec;1(3-4):239–242. doi: 10.1097/00001756-199011000-00017. [DOI] [PubMed] [Google Scholar]
- Barnes N. M., Costall B., Kelly M. E., Murphy D. A., Naylor R. J. Anxiolytic-like action of DuP753, a non-peptide angiotensin II receptor antagonist. Neuroreport. 1990 Sep;1(1):20–21. doi: 10.1097/00001756-199009000-00006. [DOI] [PubMed] [Google Scholar]
- Chiu A. T., Herblin W. F., McCall D. E., Ardecky R. J., Carini D. J., Duncia J. V., Pease L. J., Wong P. C., Wexler R. R., Johnson A. L. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989 Nov 30;165(1):196–203. doi: 10.1016/0006-291x(89)91054-1. [DOI] [PubMed] [Google Scholar]
- Gehlert D. R., Gackenheimer S. L., Reel J. K., Lin H. S., Steinberg M. I. Non-peptide angiotensin II receptor antagonists discriminate subtypes of 125I-angiotensin II binding sites in the rat brain. Eur J Pharmacol. 1990 Oct 2;187(1):123–126. doi: 10.1016/0014-2999(90)90348-a. [DOI] [PubMed] [Google Scholar]
- Song K., Allen A. M., Paxinos G., Mendelsohn F. A. Angiotensin II receptor subtypes in rat brain. Clin Exp Pharmacol Physiol. 1991 Feb;18(2):93–96. doi: 10.1111/j.1440-1681.1991.tb01414.x. [DOI] [PubMed] [Google Scholar]
- Wamsley J. K., Herblin W. F., Alburges M. E., Hunt M. Evidence for the presence of angiotensin II-type 1 receptors in brain. Brain Res Bull. 1990 Sep;25(3):397–400. doi: 10.1016/0361-9230(90)90226-p. [DOI] [PubMed] [Google Scholar]
- Wong P. C., Price W. A., Chiu A. T., Duncia J. V., Carini D. J., Wexler R. R., Johnson A. L., Timmermans P. B. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther. 1990 Feb;252(2):719–725. [PubMed] [Google Scholar]
- Wong P. C., Price W. A., Jr, Chiu A. T., Duncia J. V., Carini D. J., Wexler R. R., Johnson A. L., Timmermans P. B. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther. 1990 Oct;255(1):211–217. [PubMed] [Google Scholar]